Tianjin Tianyao Pharmaceutical Co (SHSE:600488) Piotroski F-Score: 6 (As of Aug. 29, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600488 Tianjin Tianyao Pharmaceutical Co Ltd SHSE:600488
58 GF Score
Price ¥5.60
GF Value ¥3.50
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Tianjin Tianyao Pharmaceutical Co Piotroski F-Score?

Tianjin Tianyao Pharmaceutical Co SHSE:600488 -1.75% 58 Piotroski F-Score is 6 as of Aug. 29, 2026, which is at its 10-year median of 6.00. GuruFocus rates SHSE:600488 with a GF Score™ of 58/100 and a GF Value™ of ¥3.50 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 985 Drug Manufacturers companies, Tianjin Tianyao Pharmaceutical Co ranks better than 78.58% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Tianjin Tianyao Pharmaceutical Co has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Tianjin Tianyao Pharmaceutical Co's Piotroski F-Score or its related term are showing as below:

SHSE:600488' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 6   Max: 8
Current: 6

During the past 13 years, the highest Piotroski F-Score of Tianjin Tianyao Pharmaceutical Co was 8. The lowest was 2. And the median was 6.

Tianjin Tianyao Pharmaceutical Co  (SHSE:600488) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Tianjin Tianyao Pharmaceutical Co Piotroski F-Score Related Terms


Tianjin Tianyao Pharmaceutical Co Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Tianjin Tianyao Pharmaceutical Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tianjin Tianyao Pharmaceutical Co Piotroski F-Score Chart

Tianjin Tianyao Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.00 5.00 7.00 6.00 5.00

Tianjin Tianyao Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 5.00 5.00 5.00 6.00

SHSE:600488 vs ZTS: Piotroski F-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Tianjin Tianyao Pharmaceutical Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tianjin Tianyao Pharmaceutical Co Piotroski F-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianjin Tianyao Pharmaceutical Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Tianjin Tianyao Pharmaceutical Co's Piotroski F-Score falls into.


SHSE:600488
58GF Score
Tianjin Tianyao Pharmaceutical Co Ltd SHSE:600488
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun26) TTM:Last Year (Jun25) TTM:
Net Income was 20.236 + 1.025 + 13.891 + 29.282 = ¥64 Mil.
Cash Flow from Operations was 13.187 + 103.092 + -11.352 + 203.131 = ¥308 Mil.
Revenue was 643.161 + 676.499 + 608.114 + 704.943 = ¥2,633 Mil.
Gross Profit was 247.109 + 280.29 + 255.238 + 289.236 = ¥1,072 Mil.
Average Total Assets from the begining of this year (Jun25)
to the end of this year (Jun26) was
(5858.472 + 5743.14 + 5759.692 + 5634.604 + 5749.486) / 5 = ¥5749.0788 Mil.
Total Assets at the begining of this year (Jun25) was ¥5,858 Mil.
Long-Term Debt & Capital Lease Obligation was ¥146 Mil.
Total Current Assets was ¥2,253 Mil.
Total Current Liabilities was ¥1,600 Mil.
Net Income was 44.675 + -53.245 + 58.05 + -8.746 = ¥41 Mil.

Revenue was 771.23 + 643.071 + 785.766 + 802.609 = ¥3,003 Mil.
Gross Profit was 310.663 + 318.423 + 320.694 + 341.8 = ¥1,292 Mil.
Average Total Assets from the begining of last year (Jun24)
to the end of last year (Jun25) was
(6103.331 + 5989.814 + 5698.286 + 5878.077 + 5858.472) / 5 = ¥5905.596 Mil.
Total Assets at the begining of last year (Jun24) was ¥6,103 Mil.
Long-Term Debt & Capital Lease Obligation was ¥539 Mil.
Total Current Assets was ¥2,081 Mil.
Total Current Liabilities was ¥1,289 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Tianjin Tianyao Pharmaceutical Co's current Net Income (TTM) was 64. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Tianjin Tianyao Pharmaceutical Co's current Cash Flow from Operations (TTM) was 308. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Jun25)
=64.434/5858.472
=0.01099843

ROA (Last Year)=Net Income/Total Assets (Jun24)
=40.734/6103.331
=0.00667406

Tianjin Tianyao Pharmaceutical Co's return on assets of this year was 0.01099843. Tianjin Tianyao Pharmaceutical Co's return on assets of last year was 0.00667406. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Tianjin Tianyao Pharmaceutical Co's current Net Income (TTM) was 64. Tianjin Tianyao Pharmaceutical Co's current Cash Flow from Operations (TTM) was 308. ==> 308 > 64 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Jun26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun25 to Jun26
=146.36/5749.0788
=0.02545799

Gearing (Last Year: Jun25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun24 to Jun25
=538.858/5905.596
=0.09124532

Tianjin Tianyao Pharmaceutical Co's gearing of this year was 0.02545799. Tianjin Tianyao Pharmaceutical Co's gearing of last year was 0.09124532. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Jun26)=Total Current Assets/Total Current Liabilities
=2253.276/1600.335
=1.4080027

Current Ratio (Last Year: Jun25)=Total Current Assets/Total Current Liabilities
=2081.33/1288.508
=1.61530235

Tianjin Tianyao Pharmaceutical Co's current ratio of this year was 1.4080027. Tianjin Tianyao Pharmaceutical Co's current ratio of last year was 1.61530235. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Tianjin Tianyao Pharmaceutical Co's number of shares in issue this year was 1090.113. Tianjin Tianyao Pharmaceutical Co's number of shares in issue last year was 1096.014. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=1071.873/2632.717
=0.40713567

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=1291.58/3002.676
=0.43014298

Tianjin Tianyao Pharmaceutical Co's gross margin of this year was 0.40713567. Tianjin Tianyao Pharmaceutical Co's gross margin of last year was 0.43014298. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Jun25)
=2632.717/5858.472
=0.44938629

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Jun24)
=3002.676/6103.331
=0.49197332

Tianjin Tianyao Pharmaceutical Co's asset turnover of this year was 0.44938629. Tianjin Tianyao Pharmaceutical Co's asset turnover of last year was 0.49197332. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+1+0+1+0+0
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Tianjin Tianyao Pharmaceutical Co has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 6 mean?
Tianjin Tianyao Pharmaceutical Co (SHSE:600488) has a Piotroski F-Score of 6 as of Aug. 29, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Tianjin Tianyao Pharmaceutical Co and its competitors. This is near median its historical median of 6.00. Over the past decade, Tianjin Tianyao Pharmaceutical Co's Piotroski F-Score has ranged from 2.00 to 8.00. According to the industry distribution chart, Tianjin Tianyao Pharmaceutical Co ranks #211 out of 985 companies in the Drug Manufacturers industry, placing it in the top 21.4%.
Is Tianjin Tianyao Pharmaceutical Co's Piotroski F-Score too high?
Tianjin Tianyao Pharmaceutical Co's current Piotroski F-Score of 6 is near median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 8.00. The Drug Manufacturers industry median Piotroski F-Score is 5.00. Tianjin Tianyao Pharmaceutical Co's value of 6 is 20% above this industry median. Based on the distribution chart, Tianjin Tianyao Pharmaceutical Co ranks #211 out of 985 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Tianjin Tianyao Pharmaceutical Co has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tianjin Tianyao Pharmaceutical Co's Piotroski F-Score compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Tianjin Tianyao Pharmaceutical Co ranks #211 out of 985 companies for Piotroski F-Score. This places Tianjin Tianyao Pharmaceutical Co in the top 21% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Tianjin Tianyao Pharmaceutical Co's value of 6 is 20% above this benchmark. Historically, Tianjin Tianyao Pharmaceutical Co's own Piotroski F-Score has ranged from 2.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Tianjin Tianyao Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Drug Manufacturers company?
The median Piotroski F-Score among Drug Manufacturers companies is 5.00, based on 985 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tianjin Tianyao Pharmaceutical Co's current Piotroski F-Score of 6 is 20% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Tianjin Tianyao Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tianjin Tianyao Pharmaceutical Co's current Piotroski F-Score is 6, which is near median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tianjin Tianyao Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Tianjin Tianyao Pharmaceutical Co (SHSE:600488) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥3.50, compared to a current price of ¥5.60 — trading 60% above its estimated fair value. The current Piotroski F-Score is 6, which is near median its 10-year median of 6.00 and 20% above the Drug Manufacturers industry median of 5.00. Tianjin Tianyao Pharmaceutical Co's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Tianjin Tianyao Pharmaceutical Co (SHSE:600488), the current Piotroski F-Score is 6 as of Aug. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tianjin Tianyao Pharmaceutical Co (SHSE:600488) Overvalued in 2026?

Based on GuruFocus' analysis, Tianjin Tianyao Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥5.60 is trading 60% above its estimated GF Value™ of ¥3.50. GuruFocus considers Tianjin Tianyao Pharmaceutical Co to be Significantly Overvalued.

Key valuation signals for SHSE:600488:

  • Piotroski F-Score: 6 (near median its 10-year median of 6.00)
  • GF Value™: ¥3.50 vs. price of ¥5.60 (60% above fair value)
  • GF Score™: 58/100 with 6 warning signs
  • Industry Position: 20% above the Drug Manufacturers median (#211 of 985)

No single metric tells the full story. See the SHSE:600488 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tianjin Tianyao Pharmaceutical Co Business Description

Address No. 221 Huanghai Road, Tianjin Development Zone, Tianjin, CHN, 300457
Tianjin Tianyao Pharmaceutical Co Ltd is a China-based company engages in the development, manufacture, distribution, and export of pharmaceutical products. Its products include corticosteroids and cardiovascular medicine, dexamethasone, and cortisone acetate.
58GF Score

Get the complete analysis for SHSE:600488

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥5.60
Price
¥3.50
GF Value